Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.42268 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.42372 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.37737 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.61358 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.32225 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.43346 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.41524 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.934 | 75 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.59766 | 72 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.41018 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.40939 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.426 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.36175 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.41694 | 71 |